Marshall Wace, LLP 10x Genomics, Inc. Transaction History

Marshall Wace, LLP

$72.2 Billion
Q2 2024

A detailed history of Marshall Wace, LLP transactions in 10x Genomics, Inc. stock. As of the latest transaction made, Marshall Wace, LLP holds 35,401 shares of TXG stock, worth $831,215. This represents 0.0% of its overall portfolio holdings.

Number of Shares

35,401

Holding current value

$831,215

% of portfolio

0.0%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$19.45 - $37.37 $688,549 - $1.32 Million	35,401 New	35,401 $688,000
Q4 2023 Feb 14, 2024	BUY	$34.32 - $57.55 $257,949 - $432,545	7,516 New	7,516 $420,000
Q2 2023 Aug 14, 2023	BUY	$50.96 - $58.72 $10.1 Million - $11.6 Million	197,321 New	197,321 $11 Million
Q4 2022 Feb 14, 2023	BUY	$24.4 - $41.3 $470,139 - $795,768	19,268 New	19,268 $702,000
Q1 2022 May 16, 2022	SELL	$55.7 - $145.79 $540,512 - $1.41 Million	-9,704 Closed	0 $0
Q4 2021 Feb 14, 2022	SELL	$135.05 - $182.59 $38.8 Million - $52.5 Million	-287,639 Reduced 96.74%	9,704 $1.45 Million
Q3 2021 Nov 15, 2021	BUY	$145.58 - $192.14 $43.3 Million - $57.1 Million	297,343 New	297,343 $43.3 Million
Q1 2021 May 17, 2021	SELL	$140.25 - $196.86 $36.1 Million - $50.6 Million	-257,149 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$126.47 - $163.7 $20.9 Million - $27.1 Million	165,325 Added 180.05%	257,149 $36.4 Million
Q3 2020 Nov 16, 2020	BUY	$87.44 - $125.0 $6.38 Million - $9.12 Million	72,924 Added 385.84%	91,824 $11.4 Million
Q2 2020 Aug 13, 2020	SELL	$58.39 - $89.31 $2.33 Million - $3.56 Million	-39,859 Reduced 67.83%	18,900 $1.69 Million
Q1 2020 May 15, 2020	BUY	$51.57 - $106.62 $3.03 Million - $6.26 Million	58,759 New	58,759 $3.66 Million

Others Institutions Holding TXG

# of Institutions

284

Shares Held

96.2M

Call Options Held

162K

Put Options Held

107K

Vanguard Group Inc Valley Forge, PA

10.2M
Shares

$239 Million
0.0% of portfolio
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl

9.31M
Shares

$219 Million
1.65% of portfolio
Black Rock Inc. New York, NY

6.39M
Shares

$150 Million
0.0% of portfolio
Nikko Asset Management Americas, Inc.

6.15M
Shares

$144 Million
1.4% of portfolio
Sumitomo Mitsui Trust Holdings, Inc.

6.14M
Shares

$144 Million
0.09% of portfolio

View Full List

About 10x Genomics, Inc.

Ticker TXG
Exchange NASDAQ
Sector Healthcare
Industry Health Information Services
Shares Outstandng 95,046,400
Market Cap $2.23B
Description
10x Genomics, Inc., a life science technology company, develops and sells instruments, consumables, and software for analyzing biological systems in North America, Europe, the Middle East, Africa, China, and the Asia Pacific. The company provides chromium and chromium connect instruments, microfluidic chips, slides, reagents, and other consumabl...

More about TXG

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Marshall Wace, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Marshall Wace, LLP with notifications on news.

Account